--Tina1
Thanks for the Nomura info. The trouble with the analysis is that Hambro's already have nealy 30% of the stock bought for around a £1. With the stock sitting at 92p if someone offered you 150p would you say no or take the money and run? I think most institutions will do the later hence the large discount to cash. For some the resolution of the Isostent case is not forgone which could wipe out much of the remaining cash. I think Hambros will force the company to settle the dispute so they can sell the business.
Cheers
2Bob
ps maxwellsdemon Thanks for toning the post down. Either I had red eye after too much drink or the monitor is going wonky. Couldn't be the former surely?
Biocompatibles stock quotes
Biocompatibles stock charts
Follow this thread
